C4 Therapeutics, Inc. vs. Foghorn Therapeutics Inc.

Explore the PTAB proceeding PGR2024-00005 filed by C4 Therapeutics, Inc. on 2023-10-23. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Proceeding Overview

Proceeding Number

PGR2024-00005

Filing Date

2023-10-23

Accorded Filing Date

2023-10-23

Institution Decision Date

2024-01-23

Last Modified Date

2024-03-27

Proceeding Type

PGR

Termination Date

2024-01-23

Trial Status

Institution Denied

Parties & Counsel

Petitioner

C4 Therapeutics, Inc.

Represented By

Knowles, Sherryet al

Patent Owner / Respondent

Foghorn Therapeutics Inc.

Represented By

Shinall, Michael

Tribunal & Venue

Tribunal

Patent Trial and Appeal Board (USPTO)

Technology Center

TC 1600 - Biotechnology & Organic Chemistry

Patent Information

1 Patent Involved

Respondent Application Number 17696656

Respondent Patent Number 11560381

External Links

Espacenet

Google Patents

Respondent Inventor Sabine K. RUPPEL et al

Respondent Tech Center TC 1600 - Biotechnology & Organic Chemistry

Address and Attorney/Agent Information

10 Registered Practitioners

Power of Attorney & Correspondence

Firm / Entity Name Clark+Elbing LLP

Customer Number 21559

Address One Financial Center, Suite 2110, BOSTON, MA, 02111, UNITED STATES

Attorney / Agent Information

Reg #	Name	Phone
35238	Karen Elbing	617-428-0200
42885	Susan Michaud	617-428-0200
43580	James Decamp	617-428-0200
51649	Jeffrey Ellison	617-428-7022
52011	J Mcdonald	617-428-7025
52290	Jan Tittel	617-428-7050
52608	Michael Belliveau	617-428-0200
54590	Richard Armstrong	617-428-7036
70887	Thomas Takara	617-428-0200
76944	Justin Quartararo	617-897-2090

Proceeding Documents

Notice: refund approved NOTICE

2024-03-27 FILING PARTY: BOARD

Download

Request for Refund OTHER

2024-03-26 FILING PARTY: PETITIONER

Download

3001

Exhibit 3001 Exhibit

2024-01-23 FILING PARTY: BOARD

Download

Institution Decision: Denying Institution of Post-Grant Review Due to Disclaimer of All Challenged Claims 35 U.S.C. sec. 324; 37 C.F.R. sec. 42.207e DECISION

2024-01-23 FILING PARTY: BOARD

Download

2001

Ex. 2001 - Statutory Disclaimer of US 11560381 Exhibit

2024-01-18 FILING PARTY: PATENT OWNER

Download

C4 Therapeutics, Inc. vs. Foghorn Therapeutics Inc.

Proceeding Overview

Parties & Counsel

Petitioner

C4 Therapeutics, Inc.

Represented By

Patent Owner / Respondent

Foghorn Therapeutics Inc.

Represented By

Tribunal & Venue

Patent Information

Address and Attorney/Agent Information

Power of Attorney & Correspondence

Attorney / Agent Information

Proceeding Documents

Notice: refund approved NOTICE

Request for Refund OTHER

Exhibit 3001 Exhibit

Institution Decision: Denying Institution of Post-Grant Review Due to Disclaimer of All Challenged Claims 35 U.S.C. sec. 324; 37 C.F.R. sec. 42.207e DECISION

Ex. 2001 - Statutory Disclaimer of US 11560381 Exhibit

Notice : Mandatory Notice NOTICE

Notice : Power of Attorney NOTICE

Notice: Notice filing date accorded NOTICE

Declaration of Stevan W. Djuric, Ph.D. Exhibit

File History of U.S. Patent No. 11,560,381 Exhibit

Luby-Phelps, Internation. Rev. of Cytology, Volume 192, 1999, Pages 189-221 Exhibit

PCT/US2020/015746 Exhibit

Declaration of Kevin Sprott, Ph.D. Exhibit

Brien et al., Elife. 2018 Nov 15;7:e41305 Exhibit

Hohmann et. al., Nature Chemical Biology, 12, 672-679 (2016) Exhibit

Nasir & Jolley, Comb. Chem & High Throughput Screening 2, 177-190 (1999) Exhibit

U.S.S.N. 63/061,659 Exhibit

U.S. Patent No. 11,560,381 Exhibit

U.S.S.N. 17/541,035 Exhibit

Petition : as filed PETITION

U.S.S.N. 17/425,153 Exhibit

Notice : Power of Attorney NOTICE

Martin, et al, J. Med. Chem. 59(10):4462-4475 (2016) Exhibit

Declaration of Christopher G. Nasveschuk, Ph.D. Exhibit

PCT/US2021/021240 Exhibit

U.S.S.N. 62/985,774 Exhibit

U.S.S.N. 62/798,374 Exhibit

Remillard, et al, Angew. Chem Int Ed Engl. 56(21):5738-5743 (2017) Exhibit

Rao, et al., CN 108690020 Exhibit

US 2022-0098194 A1 Exhibit

U.S.S.N. 17/478,505 Exhibit

Sender et al., PLOS Biology 14(8): e1002533 (2016) Exhibit

Z.X. Wang, FEBS Lett 1995 Feb 27;360(2):111-4 Exhibit

U.S.S.N. 62/881,195 Exhibit

WO2021/178920 Exhibit